Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-06-27T00:22:36.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T19:13:27.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T08:11:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:41:23.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:48:23.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study information about VIS649 for IgAN, while retaining some identifiers and roles related to the study.
    Difference
    26%
    Check dated 2025-04-16T01:37:21.000Z thumbnail image

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.